Kidney News and Research

RSS

Revolutionizing liver transplants in pigs with magnetic anastomosis technology

The effectiveness of magnetic anastomosis technology (MAT) in Liver Transplantation.

21 Nov 2023

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

The impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4+ (CD4+ ) Thymus cells (T cells) viz.

21 Nov 2023

Extra fees drive assisted living profits

Assisted living centers have become an appealing retirement option for hundreds of thousands of boomers who can no longer live independently, promising a cheerful alternative to the institutional feel of a nursing home.

20 Nov 2023

Immunogenicity of insect-specific Zika virus-vectorized vaccine candidates

The immunogenicity, safety, and effectiveness of ARPV/ZIKV a chimeric insect-specific flavivirus (ISFV)-Zika vaccine.

17 Nov 2023

Ketogenic diets and diabetes: A promising match or a questionable pair?

A recent research article in "Diabetes Therapy" examines the effectiveness of ketogenic diets in managing Type 1, Type 2, and gestational diabetes. Despite potential benefits like weight loss and improved glycemic control, the study highlights unresolved issues and the need for more extensive research before incorporating ketogenic diets into clinical guidelines for diabetes management.

16 Nov 2023

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Study discovers that coffee, especially its bioactive compounds like chlorogenic acids, can inhibit SARS-CoV-2 entry and reduce ACE2 and TMPRSS2 levels, indicating that coffee intake might be a potential dietary strategy for COVID-19 prevention.

16 Nov 2023

AI model predicts patient outcomes across multiple cancer types

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types.

16 Nov 2023

Study challenges health benefits of artificially sweetened beverages, links to increased health risks

An umbrella review in Advances in Nutrition, examining previous systematic reviews and meta-analyses, reveals that regular consumption of artificially sweetened beverages (ASBs) is associated with increased risks of obesity, all-cause mortality, hypertension, type 2 diabetes, and cardiovascular disease, challenging the perception of ASBs as a healthier alternative to sugar-sweetened beverages.

15 Nov 2023

New vaccine promotes immune regulation that treats autoimmunity and prolongs transplant survival

A subtype of CD8 T cells, which are classically known to promote immune system responses, may be in fact regulating the immune system by suppressing immune cells causing self-destructive responses leading to autoimmune disorders and organ graft rejection.

15 Nov 2023

UVA researchers receive NIH grant to optimize online weight-management programs for rural residents

University of Virginia School of Medicine public health researchers, together with colleagues at the University of South Carolina, have received a $3.37 million grant from the National Institutes of Health to determine if online behavioral weight-management programs for rural residents can be improved by adding a human touch.

15 Nov 2023

Adult children discuss the trials of caring for their aging parents

I am 39 years old. I had to care for my father, who passed from cancer in 2019; my mother, who passed in November 2021 from cancer; and since my mother's passing, I have inherited the care of my grandmother.

14 Nov 2023

Facing financial ruin as costs soar for elder care

Margaret Newcomb, 69, a retired French teacher, is desperately trying to protect her retirement savings by caring for her 82-year-old husband, who has severe dementia, at home in Seattle.

14 Nov 2023

Study shows environment's pivotal role in healthy aging and disease prevention

Study explores new geroscience tools for studying the impact of environmental factors on aging, aiming to delay age-related diseases and disabilities. It highlights how non-genetic factors, like environmental toxins and socio-economic conditions, significantly influence aging and health outcomes.

13 Nov 2023

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

An intensive three-year intervention to lower the top blood pressure number to less than 120 mm Hg was more effective at preventing death, heart attack, stroke and other cardiovascular events in adults at high risk for cardiovascular disease, compared to the standard treatment target of under 140 mm Hg, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

New drug zilebesiran effectively lowers blood pressure for six months, study finds

A single injection of the experimental medication zilebesiran was safe and effective in reducing systolic blood pressure in people with mild-to-moderate high blood pressure for up to six months, as detailed in the Phase 2 of the KARDIA study, reported as late-breaking science today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Pioneering study finds predictive biomarker in lung adenocarcinoma

The potential of the transcriptome of tumor-adjacent normal lung tissue in predicting the prognosis of lung cancer.

13 Nov 2023

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.

13 Nov 2023

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.

12 Nov 2023

Obinutuzumab shows promise in preserving kidney function, preventing flares in lupus nephritis patients

In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab-;an antibody that targets a protein expressed on certain immune cells-;was superior to placebo for preserving kidney function and preventing flares in patients with lupus nephritis, a kidney condition associated with the autoimmune disease lupus.

10 Nov 2023

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

A new calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to a new American Heart Association Scientific Statement published today in the Association's flagship journal Circulation.

10 Nov 2023

Kidney News and Research

Revolutionizing liver transplants in pigs with magnetic anastomosis technology

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

Extra fees drive assisted living profits

Immunogenicity of insect-specific Zika virus-vectorized vaccine candidates

Ketogenic diets and diabetes: A promising match or a questionable pair?

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

AI model predicts patient outcomes across multiple cancer types

Study challenges health benefits of artificially sweetened beverages, links to increased health risks

New vaccine promotes immune regulation that treats autoimmunity and prolongs transplant survival

UVA researchers receive NIH grant to optimize online weight-management programs for rural residents

Adult children discuss the trials of caring for their aging parents

Facing financial ruin as costs soar for elder care

Study shows environment's pivotal role in healthy aging and disease prevention

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

New drug zilebesiran effectively lowers blood pressure for six months, study finds

Pioneering study finds predictive biomarker in lung adenocarcinoma

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

Obinutuzumab shows promise in preserving kidney function, preventing flares in lupus nephritis patients

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News